A multicentre phase II study of vorinostat in patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma

Although initial rituximab-containing chemotherapies achieve high response rates, indolent B-cell non-Hodgkin lymphoma (B-NHL), such as follicular lymphoma (FL), is still incurable. Therefore, new effective agents with novel mechanisms are anticipated. In this multicentre phase II study, patients wi...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Br J Haematol
Prif Awduron: Ogura, Michinori, Ando, Kiyoshi, Suzuki, Tatsuya, Ishizawa, Kenichi, Oh, Sung Yong, Itoh, Kuniaki, Yamamoto, Kazuhito, Au, Wing Yan, Tien, Hwei-Fang, Matsuno, Yoshihiro, Terauchi, Takashi, Yamamoto, Keiko, Mori, Masahiko, Tanaka, Yoshinobu, Shimamoto, Takashi, Tobinai, Kensei, Kim, Won Seog
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BlackWell Publishing Ltd 2014
Pynciau:
Haematological Malignancy
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4282031/
https://ncbi.nlm.nih.gov/pubmed/24617454
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.12819
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg